{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial Comparing Free Dermal Fat Graft and Superficial Musculoaponeurotic System Flap in Superficial Parotidectomy"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In a single-centre, prospective randomised controlled trial, 78 adult patients undergoing superficial conservative parotidectomy for benign indications were randomised into two groups using a closed envelope method."
      },
      "Participants": {
        "score": 2,
        "evidence": "78 adult patients undergoing superficial conservative parotidectomy for benign indications"
      },
      "Intervention": {
        "score": 2,
        "evidence": "One group received FDFG, and the other received SMAS flap."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to compare the functional and aesthetic outcomes of free dermal fat graft (FDFG) and superficial musculoaponeurotic system (SMAS) flap in reducing these complications."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the development of Frey\u2019s syndrome, assessed at 6 months postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was concealed, and outcome assessors were blinded."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Randomisation was concealed, and outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Seventy-eight patients were randomised equally between February 2016 and October 2021."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Seventy-eight patients were randomised equally between February 2016 and October 2021."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "There was no significant difference in the development of Frey\u2019s syndrome between the FDFG and SMAS groups."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant differences were found in demographic data, co-morbidities, parotid pathologies, specimen volumes, total operating time, or postoperative complications."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT05452837."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 20,
    "max_score": 25
  },
  "model": "gpt-4o"
}